Mission Bio News and Activities

View the org chart displaying its 10 main executives

Most searched biographies at Mission Bio

• Brian Kim, Chief Executive Officer and Director
• Luke Hayes, Chief Financial Officer
• Matthew Cato, Chief Commercial Officer

Popular executive movements at Mission Bio

• Zivjena Vucetic has joined the company as Chief Medical Officer  (posted on October 9 2025).

Create your alert
to follow the executive moves at Mission Bio.

Mission Bio has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Mission Bio

• Mission Bio Showcases Critical Insights Into Multiple Myeloma, AML MRD, CAR-T Safety & Integrated Single-Cell DNA and Fusion Profiling at the 2024 ASH Annual Meeting | Mission Bio
• Mission Bio Partners With Top Researchers From University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma Patients | Mission Bio
• Mission Bio Launches Innovative Single-cell Genome Integrity Solution to Measure Whole Genome Copy Number Variation in Advanced Therapies and Tumor Samples | Mission Bio
• Mission Bio’s Tapestri Platform Utilized in Development of Advancements in Gene-Edited T-Cell Therapy | Mission Bio
• Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion | Mission Bio
• Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform Translational Research and Therapy Development | Mission Bio
• Ginkgo Bioworks, Novo Nordisk Partnership, Mission Bio Updates Platform, PathAI, Google Cloud Team Up, More
• Mission Bio’s Tapestri Platform Unveils Insights into Targeted Therapy and Residual Disease Assessment for Multiple Myeloma | Mission Bio
• Mission Bio's New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products | Mission Bio
• Enhancing CRISPR: Utilizing Single-Cell Multiomics for CRISPR-based Drug Product Analysis
• View more press releases Close

Social media about Mission Bio

• Mission Bio on Wikipedia, Google News & Yahoo Finance
• Mission Bio on LinkedIn, X (Twitter) & YouTube